Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model.

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

June 19, 2023

Study Completion Date

October 4, 2023

Conditions
HistopathologyWrinkleRhytides
Interventions
DEVICE

ellacor® Micro-Coring procedure

ellacor® Micro-Coring Technology is FDA approved for use by medical professionals for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV.

Trial Locations (1)

75231

Dallas Plastic Surgery Institute, Dallas

Sponsors
All Listed Sponsors
collaborator

Dallas Plastic Surgery Institute

OTHER

lead

Cytrellis Biosystems, Inc.

INDUSTRY

NCT06421207 - Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model. | Biotech Hunter | Biotech Hunter